Joel Greenblatt’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Other funds holding AKBA
Joel Greenblatt's AKBA Position: Q3 2026 in Review
Joel Greenblatt sold out of Akebia Therapeutics (AKBA) in Q3 2026, closing a stake of 36,053 shares — an estimated $41.1K sold.
Joel Greenblatt first reported a position in AKBA in Q2 2021 and held it in 6 quarters. The position peaked at $73K in Q2 2021. 157 funds tracked by Wall St. Rank hold AKBA as of Q3 2026.
- Joel Greenblatt reported no remaining Akebia Therapeutics position as of Q3 2026 after selling out during the quarter.
- Joel Greenblatt sold 36,053 Akebia Therapeutics shares in Q3 2026, an estimated $41.1K.
- Joel Greenblatt first reported a position in Akebia Therapeutics in Q2 2021 and held it in 6 quarters.
- Joel Greenblatt's Akebia Therapeutics position peaked at $73K in Q2 2021.
- 157 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.